Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-05

FDA Approved: ERLOTINIB — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' generic Erlotinib (ERLOTINIB) under an Original Application (ANDA), providing a generic option for the brand-name ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLOTINIB (Erlotinib)

Snippet

ORIG AP for ERLOTINIB (ERLOTINIB)